Moog Inc.
$362.81+$15.33 (+4.41%)
Moog Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.17% below the high.
NYSE · MIR · USD
Stock price, earnings
Quote as of Oct 29, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Mirion Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.34% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Mirion Technologies, Inc.’s next earnings report is currently expected on Feb 9, 2027, with estimated earnings per share of $0.20. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Mirion Technologies, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Mirion Technologies, Inc., established in 2005 and formerly known as Global Monitoring Systems, Inc. until its name change in January 2006, is based in Atlanta, Georgia. The company specializes in providing a comprehensive suite of specialized solutions for radiation detection, measurement, analysis, and monitoring. Its operations span a wide international footprint, covering countries such as the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, the Netherlands, Estonia, and Japan. The business is organized into two distinct operating segments: Medical and Industrial. The Medical segment delivers critical solutions aimed at enhancing patient safety and treatment accuracy within healthcare environments. Offerings here include quality assurance and dosimetry tools for radiation oncology, specialized patient safety systems for diagnostic imaging and radiation therapy centers, and precision calibration and verification solutions for medical imaging and treatment accuracy. Furthermore, it supplies radionuclide therapy products, which encompass shielding, handling equipment, dedicated medical imaging furniture, and rehabilitation aids for nuclear medicine applications. This segment fundamentally supports advancements in medical diagnostics, cancer treatment, professional safety for practitioners, and patient recovery. Conversely, the Industrial segment addresses vital requirements in radiation safety, measurement, and analysis across non-medical industries. It furnishes clients with personal radiation detection devices, identification equipment, and advanced analytical instrumentation. Mirion's extensive product and solution portfolio includes a variety of items such as nuclear medicine preparations, personal dosimeters, contamination and clearance monitoring systems, and sophisticated reactor instrumentation and control equipment. They also provide both medical and industrial imaging systems along with their related accessories, in addition to specialized instruments for alpha spectroscopy, alpha/beta counting, and gamma spectroscopy detector systems. Supplementary offerings include electrical penetration components, cancer diagnostic tools, software solutions, and a range of other services. Mirion serves a broad and varied clientele across numerous sectors. This includes healthcare providers like hospitals, clinics, urgent care facilities, dental and veterinary offices, and specialized radiation treatment centers, as well as original equipment manufacturers (OEMs) for radiation therapy. Beyond healthcare, their customers extend to research laboratories, military organizations, governmental agencies, various industrial enterprises, power and utility companies, reactor design firms, and nuclear power plants (NPPs).
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:25 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q2 2025 | Jul 31, 2025 | $0.11+10.0% vs estimate | $222.90M+0.17% vs estimate |
|---|
| Q1 2025 | Apr 29, 2025 | $0.100.0% vs estimate | $202.00M-7.81% vs estimate |
|---|
| Q4 2024 | Feb 11, 2025 | $0.17+21.43% vs estimate | $254.30M+3.79% vs estimate |
|---|
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
THE ANALYST VIEW
9 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
Percentages compare targets with the quoted price when currencies match. Targets are analyst estimates, not guaranteed outcomes.
Consensus coverage: 5 contributors · Median target $23.00.
Average targets in published notes for each window. These figures use a different sample from the consensus above.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$362.81+$15.33 (+4.41%)
Moog Inc.’s quoted price sits in the upper half of its reported 52-week range, 19.17% below the high.
$26.25+$0.33 (+1.27%)
Gates Industrial Corporation plc’s quoted price sits in the upper half of its reported 52-week range, 13.48% below the high.
$284.44+$1.40 (+0.49%)
EnPro Industries, Inc.’s quoted price sits in the lower half of its reported 52-week range, 27.15% below the high.
$110.44+$2.84 (+2.64%)
JBT Marel Corporation’s quoted price sits in the lower half of its reported 52-week range, 35.11% below the high.
$49.93+$0.55 (+1.11%)
GXO Logistics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 25.31% below the high.
$117.59+$3.55 (+3.11%)
The Middleby Corporation’s quoted price sits in the lower half of its reported 52-week range, 20.84% below the high.
$91.71+$7.35 (+8.71%)
Construction Partners, Inc.’s quoted price sits in the lower half of its reported 52-week range, 39.26% below the high.
$18.80+$0.49 (+2.68%)
Resideo Technologies, Inc.’s quoted price sits in the lower half of its reported 52-week range, 38.85% below the high.